Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey A Durocher

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Visualized Experiments : Jove|September 3, 2013
Pyrosequencing for microbial identification and characterizationPatrick J Cummings, Ray Ahmed, Jeffrey A Durocher, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 11, 2006
The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiationCatriona H M Jamieson, Jason Gotlib, Jeffrey A Durocher, et al.
Blood|June 24, 2005
Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutationJason Gotlib, Caroline Berubé, Joseph D Growney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2008
Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumorsMichael L Nickerson, Erich Jaeger, Yangu Shi, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Visualized Experiments : Jove|September 3, 2013
Pyrosequencing for microbial identification and characterizationPatrick J Cummings, Ray Ahmed, Jeffrey A Durocher, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 11, 2006
The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiationCatriona H M Jamieson, Jason Gotlib, Jeffrey A Durocher, et al.
Blood|June 24, 2005
Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutationJason Gotlib, Caroline Berubé, Joseph D Growney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2008
Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumorsMichael L Nickerson, Erich Jaeger, Yangu Shi, et al.
Pageof 1